Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
21 Oct 2024 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 31/12/23
|
|
|
21 Oct 2024 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 31/12/23
|
|
|
21 Oct 2024 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 31/12/23
|
|
|
25 Sep 2024 |
AA |
Accounts for a dormant company made up to 31 December 2023
|
|
|
02 Jan 2024 |
CS01 |
Confirmation statement made on 2 January 2024 with no updates
|
|
|
28 Sep 2023 |
AA |
Accounts for a dormant company made up to 31 December 2022
|
|
|
22 Sep 2023 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 31/12/22
|
|
|
22 Sep 2023 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 31/12/22
|
|
|
22 Sep 2023 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 31/12/22
|
|
|
03 Jan 2023 |
CS01 |
Confirmation statement made on 2 January 2023 with no updates
|
|
|
28 Dec 2022 |
TM01 |
Termination of appointment of Paul Allen as a director on 20 December 2022
|
|
|
28 Dec 2022 |
AP01 |
Appointment of Mr Jonathan Paul Turner as a director on 20 December 2022
|
|
|
28 Dec 2022 |
AP01 |
Appointment of Mr James Gareth Short as a director on 20 December 2022
|
|
|
28 Dec 2022 |
AP03 |
Appointment of Ms Kerin Williams as a secretary on 20 December 2022
|
|
|
30 Sep 2022 |
AA |
Accounts for a dormant company made up to 31 December 2021
|
|
|
29 Mar 2022 |
MISC |
Statement of fact - name correction incorrect name - celadon pharmaceuticals - correct name celadon pharmaceuticals (uk) LTD
|
|
|
25 Mar 2022 |
CERTNM |
Company name changed celadon pharmaceuticals LTD\certificate issued on 25/03/22
-
RES15 ‐
Change company name resolution on 2022-03-17
-
ANNOTATION
Clarification company name change on the 25TH March 2022 with company name incorrectly shown as celadon pharmaceuticals and not as celadon pharmaceuticals (uk) LTD erroneously shown on the face of the certificate of change of name dated 25TH March 2022
|
|
|
25 Mar 2022 |
CONNOT |
Change of name notice
|
|
|
16 Jan 2022 |
CS01 |
Confirmation statement made on 2 January 2022 with no updates
|
|
|
30 Sep 2021 |
AA |
Accounts for a dormant company made up to 31 December 2020
|
|
|
05 May 2021 |
PSC05 |
Change of details for Vertigrow Technology Limited as a person with significant control on 1 May 2021
|
|
|
05 May 2021 |
CH01 |
Director's details changed for Mr Paul Allen on 1 May 2021
|
|
|
03 Mar 2021 |
AD01 |
Registered office address changed from 165 Fleet Street London EC4A 2DY England to 32-33 Cowcross Street London EC1M 6DF on 3 March 2021
|
|
|
03 Mar 2021 |
AA01 |
Previous accounting period shortened from 31 January 2021 to 31 December 2020
|
|
|
02 Feb 2021 |
AA |
Accounts for a dormant company made up to 31 January 2020
|
|